Yanchang Wang | Genomics | Best Researcher Award

Prof. Dr. Yanchang Wang | Genomics | Best Researcher Award

Wuhan Botanical Garden (CAS) | China 

Author Profile

Scopus

🌱 PROFESSOR DR. YANCHANG WANG: ADVANCING BOTANICAL RESEARCH AT THE WUHAN BOTANICAL GARDEN, CAS, CHINA 🌍

EARLY ACADEMIC PURSUITS 🎓

Prof. Dr. Yanchang Wang embarked on his journey in botanical sciences with a profound passion for plants and their ecological significance. He pursued his undergraduate studies in botany, excelling in plant taxonomy and conservation. His academic drive led him to complete postgraduate education with a focus on molecular biology and its applications in plant sciences, culminating in a doctorate in a prestigious institution.

PROFESSIONAL ENDEAVORS 🧑‍🔬

As a Research Scholar at the Wuhan Botanical Garden, Chinese Academy of Sciences (CAS), Dr. Wang has held pivotal roles in fostering scientific excellence. His career has involved mentoring emerging researchers, contributing to critical national projects, and collaborating with international botanical organizations. Dr. Wang's tenure has been marked by groundbreaking studies in plant biodiversity, conservation strategies, and molecular ecology.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENOMICS 🔬

Dr. Wang’s research delves into plant-environment interactions, focusing on ecological adaptation, conservation genomics, and the sustainable use of plant resources. His contributions include:

  • Identifying rare plant species and devising strategies for their conservation.
  • Applying advanced molecular techniques to understand plant genetic diversity.
  • Publishing widely on climate-resilient plants and their ecological roles.

IMPACT AND INFLUENCE 🌟

Dr. Wang’s work has had a far-reaching impact on biodiversity conservation, earning him recognition as a thought leader in botanical sciences. He has shaped policies for sustainable ecosystem management, influenced conservation strategies, and fostered awareness on the global significance of plant biodiversity.

ACADEMIC CITATIONS 📚

With numerous high-impact journal publications, Dr. Wang has earned extensive academic citations, reflecting the significance and applicability of his research. His h-index underscores his contributions to the scientific community and the widespread influence of his work on plant sciences and conservation efforts.

LEGACY AND FUTURE CONTRIBUTIONS 🌏

Prof. Dr. Yanchang Wang’s legacy is defined by his commitment to ecological integrity and the protection of plant biodiversity for future generations. He continues to inspire through innovative research, impactful collaborations, and by empowering the next generation of scientists to address global environmental challenges. His future endeavors promise to further expand knowledge in plant biology, with an emphasis on sustainability and ecological harmony.

NOTABLE PUBLICATIONS 📑

"Transcriptome analysis identified a transcriptional repressor, BES1-INTERACTING MYC-LIKE1 regulating rapid postharvest fruit softening of Actinidia arguta

  • Authors: Wang, J. , Lu, X.-M. , Kuang, M.-M. , Wang, W.-Q. , Wang, Y.-C.
  • Journal: Postharvest Biology and Technology
  • Year: 2024

"Genome assembly of autotetraploid Actinidia arguta highlights adaptive evolution and enables dissection of important economic traits

  • Authors: Lu, X.-M. , Yu, X.-F. , Li, G.-Q. , Wu, J.-H. , Wang, Y.-C.
  • Journal: Plant Communications
  • Year: 2024

"Chromosome-level genome of putative autohexaploid Actinidia deliciosa provides insights into polyploidisation and evolution

  • Authors: Liu, Y. , Zhou, Y. , Cheng, F. , Quan, Z. , Li, J.
  • Journal: Plant Journal
  • Year: 2024

"Stable plastid transformation in kiwifruit (Actinidia chinensis)

  • Authors: Chen, Q. , Wu, Y. , Wang, Y. , Zhang, J. , Li, S.
  • Journal: BIOTECH
  • Year: 2024

"Screening of Kiwifruit Canker Resistance-Related Genes Based on the Transcriptome Sequencing Analysis of Hybrids from Actinidia chinensis

  • Authors: Kuang, M. , Li, L. , Ma, J. , Wang, Y. , Liu, S
  • Journal: Acta Horticulturae Sinica
  • Year: 2024

Siyang Liu | Bioinformatics | Best Researcher Award

Dr. Siyang Liu | Bioinformatics | Best Researcher Award

Sun Yat-Sen University | China

Author Profile

Scopus

Orcid ID

Google Scholar

📊 Dr. Siyang Liu: A Leader in Human Statistical Genetics and Bioinformatics

EARLY ACADEMIC PURSUITS 🎓

Dr. Siyang Liu began her academic journey with a Bachelor's in Ecology from Sun Yat-sen University’s Department of Life Science (2007-2011), where she received a China National Governmental Scholarship for her academic performance. Her interest in bioinformatics led her to pursue an MSc and subsequently a Ph.D. in Bioinformatics at the Bioinformatics Center, University of Copenhagen. Supervised by esteemed Professors Anders Krogh and Anders Albrechtsen, she developed a robust foundation in bioinformatics, further supported by the Danish Government Scholarship.

PROFESSIONAL ENDEAVORS 👩‍🔬

Dr. Liu is a tenured Associate Professor at the School of Public Health (Shenzhen), Sun Yat-sen University. She also holds concurrent posts as a Professor in Genomics at BGI-Shenzhen Life-Science Institute and a Professor in Bioinformatics at the Center of Excellence for Omics Research, Beijing Tiantan Hospital. Before her current role, she was a Senior Research Scientist at BGI-Shenzhen Life-Science Institute (2018–2021).

CONTRIBUTIONS AND RESEARCH FOCUS ON BIOINFORMATICS🔬

Dr. Liu's research group primarily investigates human statistical genetics and bioinformatics. Her expertise lies in analyzing genetic, environmental, and molecular factors that contribute to human diseases and traits. She uses a combination of bioinformatics, statistical, and machine learning techniques to study the molecular and systemic etiology of complex diseases. Her goal is to develop predictive and intervention models for these diseases, benefiting individuals and populations alike.

IMPACT AND INFLUENCE 🌎

Dr. Liu’s research has contributed significantly to the understanding of complex diseases through the development of genomic and bioinformatics models. Her work is widely recognized in high-impact journals, with over 20 publications as (co-)first or (co-)corresponding author in journals such as Cell, Nature, Blood, and Nature Communications. Her findings have provided insights into both the predictive modeling of disease and the influence of various genetic and environmental factors on human health.

ACADEMIC CITES 📚

Her body of work is extensively cited in the fields of genomics, bioinformatics, and statistical genetics. This academic impact underscores the relevance and influence of her contributions to scientific knowledge, with her publications helping to advance both the understanding and practical application of complex bioinformatics models.

LEGACY AND FUTURE CONTRIBUTIONS 🌟

With her innovative research, teaching roles, and mentorship, Dr. Liu is shaping the next generation of scientists in the field of bioinformatics and public health. Her leadership in multi-omics projects, especially in the areas of cerebrovascular disease and respiratory virus research, demonstrates her commitment to advancing medical genomics and bioinformatics. Her work in population genetics and epidemiology has already made a lasting impact, and her ongoing projects promise to deepen our understanding of the genetic and environmental factors impacting public health.

KEY PROJECTS, GRANTS, AND TEACHING CONTRIBUTIONS💡

Dr. Liu has secured significant funding from national and provincial sources, including the National Key Research and Development Program Project and the Guangdong Provincial Basic and Applied Basic Research Fund, among others. Dr. Liu teaches a range of subjects, including Medical Informatics, Bioinformatics, and Epidemiological Methods. Her courses prepare students for practical applications in computational biology and medical statistics.

OTHER NOTABLE ACHIEVEMENTS 🏆

  • Grants: Dr. Liu has secured several substantial research grants, including the National Key Research and Development Program Project on ischemic cerebrovascular disease and respiratory viruses, underscoring her expertise in multi-omics approaches.
  • Teaching: She is an active educator, teaching courses such as Fundamentals and Experiments in Medical Informatics, Python and Computational Biology, and Epidemiological Methods, shaping the next generation of bioinformatics and medical statistics experts.
  • Honors and Awards: Dr. Liu’s accolades include the Important Scientific Research Achievement Award at BGI-Shenzhen and recognition as a Shenzhen High-level Overseas Talent, highlighting her achievements and influence within the academic and research communities.

NOTABLE PUBLICATIONS 📑

"Genome-wide association studies of thyroid-related hormones, dysfunction, and autoimmunity among 85,421 Chinese pregnancies" 

  • Authors: Wei, Y. , Zhen, J. , Hu, L. , Xiong, L. , Liu, S
  • Journal: Nature Communications
  • Year: 2024

"Efforts made, challenges faced, and recommendations provided by stakeholders involved in mpox prevention and control in China: a qualitative study" 

  • Authors: Zhang, W. , Qi, X. , Han, B. , Meng, X. , Zou, H
  • Journal: Public Health
  • Year: 2024

"Genome-wide association study of maternal plasma metabolites during pregnancy" 

  • Authors: Liu, S. , Yao, J. , Lin, L. , Jin, X. , Liu, S.
  • Journal: Cell Genomics
  • Year: 2024

"Advances in using non-invasive prenatal testing to study genomics related to maternity" 

  • Authors: Jin, X. , Xu, X. , Zhou, A. , Wang, T. , Liu, H.
  • Journal: Cell Genomics
  • Year: 2024

"Utilizing non-invasive prenatal test sequencing data for human genetic investigation" 

  • Authors: Liu, S. , Liu, Y. , Gu, Y. , Jin, X. , Huang, S.
  • Journal: Cell Genomics
  • Year: 2024

Bijina Balakrishnan | Molecular Basis of Genetic Disease | Best Researcher Award

Dr. Bijina Balakrishnan | Molecular Basis of Genetic Disease | Best Researcher Award

University of Utah | United States

Author Profile

Scopus

EARLY ACADEMIC PURSUITS

Bijina Balakrishnan embarked on her academic journey in the field of biotechnology with a Bachelor of Science degree in Biology & Chemistry from the University of Calicut, Kerala, India, in 1999. She further pursued her passion for biotechnology by obtaining a Master of Science degree in Biotechnology from Cochin University of Science and Technology, Kerala, India, in 2002. Her dedication to advancing knowledge in the field led her to pursue a Doctor of Philosophy (PhD) in Biotechnology, which she successfully completed at Cochin University of Science and Technology, Kerala, India, in 2008.

PROFESSIONAL ENDEAVORS

Balakrishnan's professional journey has been characterized by a steadfast commitment to research excellence and innovation. She has held various significant positions in esteemed academic and research institutions, including:

RESEARCH SCIENTIST University of Utah, Salt Lake City (2021 - Present)

RESEARCH ASSOCIATE University of Utah, Salt Lake City (2019 - 2021)

POST-DOCTORAL FELLOW University of Utah, Salt Lake City (2014 - 2019)

POST-DOCTORAL FELLOW Nanyang Technological University, Singapore (2008)

SENIOR RESEARCH FELLOW Kannur University, India (2007 - 2008)

GRADUATE RESEARCHER Cochin University of Science and Technology, India (2003 - 2007)

CONTRIBUTIONS AND RESEARCH FOCUS ON MOLECULAR BASIS OF GENETICS DISEASE

Balakrishnan's contributions to the field of biotechnology are multifaceted and impactful, spanning from basic research to translational applications. Her research endeavors have primarily focused on rare metabolic disorders, with a particular emphasis on Galactosemia and dilated cardiomyopathy. Some notable contributions include:

  • Development and optimization of preclinical therapeutic interventions for Galactosemia and dilated cardiomyopathy.
  • Characterization of mouse models for Galactosemia and elucidation of disease mechanisms.
  • Design and execution of gene therapy strategies for cardiac-specific conditions.
  • Profiling small molecule modulators for novel therapeutic targets.
  • Investigation of cellular responses to viral proteins, such as the SARS-CoV-2 Spike protein, and evaluation of potential therapeutic interventions.

IMPACT AND INFLUENCE

Balakrishnan's work has made a significant impact on both the scientific community and the broader field of biotechnology. Her research findings have been presented at numerous conferences and workshops, contributing to the dissemination of knowledge and fostering collaboration among scientists. Additionally, her efforts have led to the development of novel therapeutic approaches for rare metabolic disorders, offering hope to patients and clinicians alike.

ACADEMIC CITATIONS

Balakrishnan's research contributions have been recognized through academic honors and awards, including the Best Researcher Award at the International Research Awards on Cardiology and Cardiovascular Medicine. Moreover, she has received prestigious grants and funding support from organizations such as the Galactosemia Foundation and the National Institutes of Health (NIH).

LEGACY AND FUTURE CONTRIBUTIONS

Balakrishnan's legacy in the field of biotechnology is characterized by her dedication to scientific inquiry, innovation, and translational research. As she continues her professional journey, she remains committed to advancing knowledge, developing novel therapeutic interventions, and mentoring the next generation of scientists. Her future contributions are poised to further shape the landscape of biotechnology and positively impact the lives of individuals affected by rare metabolic disorders.

NOTABLE PUBLICATIONS

Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia 2020(38)

Structure-Based Optimization of Small Molecule Human Galactokinase Inhibitors 2021(3)

AAV-based gene therapy prevents and halts the progression of dilated cardiomyopathy in a mouse model of phosphoglucomutase 1 deficiency (PGM1-CDG) 2023(3)

AAV9-based PMM2 gene replacement augments PMM2 expression and improves glycosylation in primary fibroblasts of patients with phosphomannomutase 2 deficiency (PMM2-CDG)

Whole-body galactose oxidation as a robust functional assay to assess the efficacy of gene-based therapies in a mouse model of Galactosemia